These experiments showed that breast cancer patients that received treatment with TOT and whose tumors exhibited high ISG12 mRNA levels had a significant reduction in RFS with respect to patients with low expression levels of ISG12 that also received this anti-estrogen therapy. Here, IFI27 is linked to breast cancer.